1. [Different human cytomegalovirus glycoprotein B (gB) genotype distribution]
- Author
-
L, Mhiri, J-F, Meritet, P, Lebon, and A, Slim
- Subjects
Immunosuppression Therapy ,Acquired Immunodeficiency Syndrome ,Base Sequence ,Genotype ,Molecular Sequence Data ,Polymerase Chain Reaction ,Viral Envelope Proteins ,DNA, Viral ,Humans ,Amino Acid Sequence ,Prospective Studies ,Codon ,Deoxyribonucleases, Type II Site-Specific ,Bronchoalveolar Lavage Fluid ,Sequence Alignment - Abstract
The glycoprotein B (gB) is the major glycoprotein of the envelope of the human cytomegalovirus, it is encoded by UL55 open reading frame, implicated in host cell, entry cell to cell virus transmission and fusion of infected cells and a significant is an important target for immuno-reactions humoral and cellular. A prospective analysis of cytomegalovirus glycoprotein B genotype was conducted on 31 immunodepressed (transplant recipients and AIDS patients). The DNA was extracted directly from the bronchoalveolar liquid (BAL) of these patients. The gB genotypes of CMV was determined by using the polymerase chain reaction, followed by the digestion of two enzymes of restriction HinfI and RsaI. The distribution of the gB genotype of the CMV was: gB1 38,70%; gB2 25,80%; gB3 16,12% and gB4 19,35%. The analysis of the peptide sequence of this region (codons 437-520), indicate the variation was more frequent between codons 448-480.
- Published
- 2006